Antimicrobial benzodiazepine-based short cationic peptidomimetics

Galina M. Zats, Marina Kovaliov, Amnon Albeck, Shimon Shatzmiller

Research output: Contribution to journalArticlepeer-review

Abstract

Antimicrobial peptides (AMPs) appear to be good candidates for the development of new antibiotic drugs. We describe here the synthesis of peptidomimetic compounds that are based on a benzodiazepine scaffold flanked with positively charged and hydrophobic amino acids. These compounds mimic the essential properties of cationic AMPs. The new design possesses the benzodiazepine scaffold that is comprised of two glycine amino acids and which confers flexibility and aromatic hydrophobic 'back', and two arms used for further synthesis on solid phase for incorporation of charged and hydrophobic amino acids. This approach allowed us a better understanding of the influence of these features on the antimicrobial activity and selectivity. A novel compound was discovered which has MICs of 12.5 μg/ml against Staphylococcus aureus and 25 μg/ml against Escherichia coli, similar to the well-known antimicrobial peptide MSI-78. In contrast to MSI-78, the above mentioned compound has lower lytic effect against mammalian red blood cells. These peptidomimetic compounds will pave the way for future design of potent synthetic mimics of AMPs for therapeutic and biomedical applications.

Original languageEnglish
Pages (from-to)512-519
Number of pages8
JournalJournal of Peptide Science
Volume21
Issue number6
DOIs
StatePublished - 1 Jun 2015
Externally publishedYes

Keywords

  • antimicrobial peptide
  • benzodiazepine scaffold
  • cationic peptides
  • drug design
  • peptidomimetics

Fingerprint

Dive into the research topics of 'Antimicrobial benzodiazepine-based short cationic peptidomimetics'. Together they form a unique fingerprint.

Cite this